HCA Healthcare

HCA invests directly into the physical and operational infrastructure of its own network: hospital construction, equipment purchases, and ambulatory site expansion. In 2025, that totaled $5 billion in capital investment. The organization does not operate third-party funds or discretionary pooled vehicles. Instead, it allocates internally generated cash flows toward healthcare real assets where it can control operational outcomes and capture clinical revenue directly.

The firm's public disclosures do not describe a venture portfolio or external GP commitment program. Capital allocation appears concentrated in wholly owned facilities and affiliated service lines. If HCA participates in minority investments or innovation-stage healthcare ventures, those activities are not surfaced in its annual operating metrics or impact reporting as of early 2026.

Capital comes from operating cash flows generated by the 189-hospital system and its ambulatory network. HCA is a publicly traded corporation — ticker HCA on the New York Stock Exchange — and funds its investment program through retained earnings, operating revenue, and debt issuance, not external limited partner commitments.

HCA operates across 19 states with concentrated footprints in Texas, Florida, and Colorado, plus a growing presence in the United Kingdom. The firm does not publish a state-by-state capital expenditure breakdown, but facility counts and market density suggest the largest allocations flow to high-population-growth Sun Belt markets where patient volumes support new hospital and ambulatory site construction.

As a publicly traded company, HCA is governed by a board of directors and an executive leadership team. Major capital allocation decisions — including hospital acquisitions, new facility construction, and technology investments — are subject to board approval and disclosed through SEC filings. The firm's CEO, Samuel N. Hazen, has led the organization since January 2019.